Xilio Therapeutics, Inc. (XLO) Total liabilities 2024–2025
Xilio Therapeutics, Inc. (XLO) total liabilities at each fiscal year-end, per SEC filings.
$119.4MFY2025 · since FY2024: $53.5M → $119.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $119.4M | +123.3% |
| FY2024 | $53.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice